These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

248 related articles for article (PubMed ID: 14640913)

  • 1. Replacement therapy in Addison's disease.
    Løvås K; Husebye ES
    Expert Opin Pharmacother; 2003 Dec; 4(12):2145-9. PubMed ID: 14640913
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Replacement therapy for Addison's disease: recent developments.
    Løvås K; Husebye ES
    Expert Opin Investig Drugs; 2008 Apr; 17(4):497-509. PubMed ID: 18363515
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Primary adrenal failure--causes, diagnostics and therapy].
    Løvås K; Erichsen MM; Husebye ES; Fougner KJ; Svartberg J; Mella B; Myhre AG; Berg JP; Aarskog D
    Tidsskr Nor Laegeforen; 2005 Jan; 125(2):155-8. PubMed ID: 15665886
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Vertebral fractures assessed with dual-energy X-ray absorptiometry in patients with Addison's disease on glucocorticoid and mineralocorticoid replacement therapy.
    Camozzi V; Betterle C; Frigo AC; Zaccariotto V; Zaninotto M; De Caneva E; Lucato P; Gomiero W; Garelli S; Sabbadin C; Salvà M; Costa MD; Boscaro M; Luisetto G
    Endocrine; 2018 Feb; 59(2):319-329. PubMed ID: 28795340
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Subjective health status in Norwegian patients with Addison's disease.
    Løvås K; Loge JH; Husebye ES
    Clin Endocrinol (Oxf); 2002 May; 56(5):581-8. PubMed ID: 12030907
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Sexual dysfunctions in men affected by autoimmune Addison's disease before and after short-term gluco- and mineralocorticoid replacement therapy.
    Granata A; Tirabassi G; Pugni V; Arnaldi G; Boscaro M; Carani C; Balercia G
    J Sex Med; 2013 Aug; 10(8):2036-43. PubMed ID: 22429298
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Recurrent nocturnal hypoglycaemia as a cause of morning fatigue in treated Addison's disease--favourable response to dietary management: a case report.
    Petersen KS; Rushworth RL; Clifton PM; Torpy DJ
    BMC Endocr Disord; 2015 Oct; 15():61. PubMed ID: 26500000
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Management of adrenal insufficiency in different clinical settings.
    Hahner S; Allolio B
    Expert Opin Pharmacother; 2005 Nov; 6(14):2407-17. PubMed ID: 16259572
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Metabolic assessment of hydrocortisone replacement therapy in patients with primary adrenocortical insufficiency].
    Fichna M; Gryczyńska M; Sowińska A; Sowiński J
    Przegl Lek; 2011; 68(2):96-102. PubMed ID: 21751518
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Delayed diagnosis of Addison's disease: an approach to management.
    Mascarenhas JV; Jude EB
    BMJ Case Rep; 2014 Jul; 2014():. PubMed ID: 25038500
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Glucocorticoid replacement therapy in patients with Addison's disease.
    Kyriazopoulou V
    Expert Opin Pharmacother; 2007 Apr; 8(6):725-9. PubMed ID: 17425469
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Addison's disease due to familial, congenital adrenal gland hypoplasia].
    Kurz R; Ludescher E; Glatzl J; Berger H; Lederer B
    Wien Klin Wochenschr; 1971 Mar; 83(9):149-53. PubMed ID: 5561283
    [No Abstract]   [Full Text] [Related]  

  • 13. [Addison's disease : Primary adrenal insufficiency].
    Pulzer A; Burger-Stritt S; Hahner S
    Internist (Berl); 2016 May; 57(5):457-69. PubMed ID: 27129928
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Autoimmune Addison's disease.
    Betterle C; Morlin L
    Endocr Dev; 2011; 20():161-172. PubMed ID: 21164269
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Adrenal steroidogenesis after B lymphocyte depletion therapy in new-onset Addison's disease.
    Pearce SH; Mitchell AL; Bennett S; King P; Chandran S; Nag S; Chen S; Smith BR; Isaacs JD; Vaidya B
    J Clin Endocrinol Metab; 2012 Oct; 97(10):E1927-32. PubMed ID: 22767640
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Current and emerging therapies for Addison's disease.
    Napier C; Pearce SH
    Curr Opin Endocrinol Diabetes Obes; 2014 Jun; 21(3):147-53. PubMed ID: 24755997
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Salivary cortisol day curves in assessing glucocorticoid replacement therapy in Addison's disease.
    Smans L; Lentjes E; Hermus A; Zelissen P
    Hormones (Athens); 2013; 12(1):93-100. PubMed ID: 23624135
    [TBL] [Abstract][Full Text] [Related]  

  • 18. GDF15 Is Elevated in Conditions of Glucocorticoid Deficiency and Is Modulated by Glucocorticoid Replacement.
    Melvin A; Chantzichristos D; Kyle CJ; Mackenzie SD; Walker BR; Johannsson G; Stimson RH; O'Rahilly S
    J Clin Endocrinol Metab; 2020 May; 105(5):1427-34. PubMed ID: 31853550
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Group 4: Replacement therapy for adrenal insufficiency.
    Castinetti F; Guignat L; Bouvattier C; Samara-Boustani D; Reznik Y
    Ann Endocrinol (Paris); 2017 Dec; 78(6):525-534. PubMed ID: 29169608
    [No Abstract]   [Full Text] [Related]  

  • 20. The acute effect of a mineralocorticoid receptor agonist on corticotrope secretion in Addison's disease.
    Berardelli R; Karamouzis I; D'Angelo V; Fussotto B; Minetto MA; Ghigo E; Giordano R; Arvat E
    J Endocrinol Invest; 2016 May; 39(5):537-42. PubMed ID: 26450146
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 13.